Vor Biopharma Inc. · NASDAQ:VOR
Kolchinsky Peter sold 849,257 Vor Biopharma Inc. shares (Form 4)
Traded Apr 2 to Apr 6, 2026 · Filed Apr 6, 2026
From Apr 2 to Apr 6, 2026, Kolchinsky Peter (Director, 10% owner) sold 849,257 Vor Biopharma Inc. shares at an average US$17.10 for US$14.5M, leaving 4,555,741 shares. Filed Apr 6, 2026 (Form 4).
- Sold
- 849,257 shares
- Price
- US$17.10 average (US$16.51 to US$19.06)
- Value
- US$14.5M
- Holding after
- 4,555,741 shares (held indirectly)
- Trading plan
- No
- Role
- Director, 10% owner
The filing in full
| Date | Security | Transaction | Shares | Price | Holding after | Ownership |
|---|---|---|---|---|---|---|
| Apr 2, 2026 | Common Stock | Sale | 258,475 | US$18.23 | 5,146,523 | Indirect |
| Apr 2, 2026 | Common Stock | Sale | 1,525 | US$19.06 | 5,144,998 | Indirect |
| Apr 6, 2026 | Common Stock | Sale | 537,754 | US$16.51 | 4,607,244 | Indirect |
| Apr 6, 2026 | Common Stock | Sale | 44,728 | US$17.31 | 4,562,516 | Indirect |
| Apr 6, 2026 | Common Stock | Sale | 6,775 | US$18.50 | 4,555,741 | Indirect |
Source
Related
- Vor Biopharma Inc.
- Kolchinsky Peter
- Vor Biopharma Inc. shareholders
- Form 4 · Ra Capital Management, L.P. · Oct 5, 2026
- Form 4 · RA Capital Healthcare Fund LP · Aug 26, 2026
- Schedule 13G/A · Venrock Healthcare Capital Partners III, L.P. · Aug 14, 2026
- Schedule 13G/A · Frazier Life Sciences Public Fund, L.P. · Aug 14, 2026
- Schedule 13G/A · Verve Capital Limited · Aug 13, 2026